Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000751
Status:
COMPLETED
Last Update Posted:
2008-09-30
First Post:
1999-11-02
Brief Title:
A Phase III Randomized Double-Blind Controlled Study of the Use of Anti-HIV Immune Serum Globulin HIVIG for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine AZT
Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Organization Data
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Class:
NIH
Study ID:
ACTG 185
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases NIAID | NIH |